Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Lancet, 2013. Feb 9;381(9865):468-75.
Date de publication : 08 février 2013
Auteurs :
Marcellin Patrick Gane E Buti M Afdhal N Sievert W Jacobson IM Washington MK Germanidis G Flaherty JF Schall RA Bornstein JD Kitrinos KM Subramanian GM McHutchison JG Heathcode EJ